Physician profile
Fernando Itable
NPI 1871586560
$2,186.72
in general payments reported to CMS, 2019-2025
20 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,368 · 2021: $79.99 · 2022: $88.05 · 2023: $94.07 · 2024: $125 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $542.17 | 2019-2025 | Airsupra |
| Pfizer INC. | $264.44 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $227.52 | 2019 | |
| Astellas Pharma US INC | $168.68 | 2019-2021 | |
| Novo Nordisk INC | $164.17 | 2019-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $148.27 | 2019 | |
| Abbvie INC. | $118.52 | 2022-2025 | |
| Amgen INC. | $115.36 | 2019 | |
| Baxter Healthcare | $92.36 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Lilly USA, LLC | $84.23 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.45 | 2019 | |
| Allergan, INC. | $43.06 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.08 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $24.84 | 2023 | Rexulti |
| Gilead Sciences, INC. | $24.14 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.34 | 2025 | |
| Merck Sharp & Dohme LLC | $22.97 | 2019 | |
| Ironwood Pharmaceuticals, INC | $19.00 | 2019 | |
| Radius Health, INC. | $17.89 | 2019 | |
| Daiichi Sankyo INC. | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Itable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.